Variant report

Variant	nsv539939
Chromosome Location	chr9:3139007-3262791
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:808)
CpG islands
(count:368)
Chromatin interactive
region (count:16)
LncRNA
region (count:15)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:808 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:3151777-3152598	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:3150159-3150316	HepG2	liver:	n/a	n/a
3	ARID3A	chr9:3177356-3177704	HepG2	liver:	n/a	n/a
4	BACH1	chr9:3261560-3261752	H1-hESC	embryonic stem cell:	n/a	n/a
5	BACH1	chr9:3241415-3241614	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr9:3181571-3181959	H1-hESC	embryonic stem cell:	n/a	n/a
7	BCLAF1	chr9:3240643-3241100	GM12878	blood:	n/a	n/a
8	BHLHE40	chr9:3199072-3199094	A549	lung:	n/a	n/a
9	BHLHE40	chr9:3257916-3257925	GM12878	blood:	n/a	n/a
10	BHLHE40	chr9:3240677-3241034	GM12878	blood:	n/a	n/a
11	BRCA1	chr9:3181672-3181872	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr9:3181646-3182042	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr9:3155717-3155852	HepG2	liver:	n/a	chr9:3155778-3155789
14	CEBPB	chr9:3245294-3245494	HepG2	liver:	n/a	n/a
15	CEBPB	chr9:3243817-3244022	A549	lung:	n/a	chr9:3243918-3243929
16	CEBPB	chr9:3189471-3189658	K562	blood:	n/a	n/a
17	CEBPB	chr9:3258942-3259174	K562	blood:	n/a	chr9:3259056-3259067
18	CEBPB	chr9:3190854-3191011	A549	lung:	n/a	chr9:3190978-3190989 chr9:3190978-3190991
19	CEBPB	chr9:3170691-3171059	A549	lung:	n/a	chr9:3171029-3171040 chr9:3170829-3170840 chr9:3171029-3171042
20	CEBPB	chr9:3190553-3190670	H1-hESC	embryonic stem cell:	n/a	n/a
21	CEBPB	chr9:3170867-3171186	MCF-7	breast:	n/a	chr9:3171102-3171115 chr9:3171029-3171040 chr9:3171029-3171042
22	CEBPB	chr9:3261380-3261412	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr9:3243740-3244076	HepG2	liver:	n/a	chr9:3243918-3243929
24	CEBPB	chr9:3243837-3243957	K562	blood:	n/a	chr9:3243918-3243929
25	CEBPB	chr9:3190932-3191125	IMR90	lung:	n/a	chr9:3190978-3190989 chr9:3190978-3190991
26	CEBPB	chr9:3181702-3182017	MCF-7	breast:	n/a	n/a
27	CEBPB	chr9:3258936-3259232	HepG2	liver:	n/a	chr9:3259056-3259067
28	CEBPB	chr9:3215236-3215317	A549	lung:	n/a	n/a
29	CEBPB	chr9:3235532-3235874	A549	lung:	n/a	n/a
30	CEBPB	chr9:3200523-3200878	IMR90	lung:	n/a	n/a
31	CEBPB	chr9:3243794-3243977	HepG2	liver:	n/a	chr9:3243918-3243929
32	CEBPB	chr9:3252655-3252855	HepG2	liver:	n/a	chr9:3252736-3252747
33	CEBPB	chr9:3238348-3238618	HepG2	liver:	n/a	chr9:3238444-3238457 chr9:3238444-3238455
34	CEBPB	chr9:3256609-3257250	IMR90	lung:	n/a	n/a
35	CEBPB	chr9:3258929-3259187	Hela-S3	cervix:	n/a	chr9:3259056-3259067
36	CEBPB	chr9:3258925-3259226	IMR90	lung:	n/a	chr9:3259056-3259067
37	CEBPB	chr9:3238308-3238625	IMR90	lung:	n/a	chr9:3238444-3238457 chr9:3238444-3238455
38	CEBPB	chr9:3190567-3191066	HepG2	liver:	n/a	chr9:3190846-3190857 chr9:3190978-3190989 chr9:3190978-3190991 chr9:3190844-3190857
39	CEBPB	chr9:3170823-3171156	Hela-S3	cervix:	n/a	chr9:3171102-3171115 chr9:3171029-3171040 chr9:3170829-3170840 chr9:3171029-3171042
40	CEBPB	chr9:3235534-3235893	IMR90	lung:	n/a	n/a
41	CEBPB	chr9:3177376-3177660	HepG2	liver:	n/a	n/a
42	CEBPB	chr9:3235622-3235830	K562	blood:	n/a	n/a
43	CEBPB	chr9:3257081-3257085	A549	lung:	n/a	n/a
44	CEBPB	chr9:3235546-3235853	HepG2	liver:	n/a	n/a
45	CEBPB	chr9:3170663-3171095	HepG2	liver:	n/a	chr9:3171029-3171040 chr9:3170829-3170840 chr9:3171029-3171042
46	CEBPB	chr9:3258978-3259229	A549	lung:	n/a	chr9:3259056-3259067
47	CEBPB	chr9:3256616-3256833	K562	blood:	n/a	n/a
48	CEBPB	chr9:3190953-3190956	H1-hESC	embryonic stem cell:	n/a	n/a
49	CEBPB	chr9:3170780-3170873	K562	blood:	n/a	chr9:3170829-3170840
50	CEBPB	chr9:3189340-3189792	HepG2	liver:	n/a	chr9:3189464-3189475

(count:368 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:3180869-3180919	HCM	heart:	n/a
2	chr9:3180374-3180424	BJ	skin:	n/a
3	chr9:3180869-3180919	HCM	heart:	n/a
4	chr9:3180374-3180424	BJ	skin:	n/a
5	chr9:3183159-3183209	HCPEpiC	choroid plexus:	n/a
6	chr9:3183159-3183209	HIPEpiC	eye:	n/a
7	chr9:3181007-3181057	HIPEpiC	eye:	n/a
8	chr9:3183159-3183209	HCT-116	colon:	n/a
9	chr9:3180869-3180919	BJ	skin:	n/a
10	chr9:3181772-3181822	HRPEpiC	eye:	n/a
11	chr9:3181659-3181709	HepG2	liver:	n/a
12	chr9:3181772-3181822	HAEpiC	amniotic membrane:	n/a
13	chr9:3181772-3181822	ovcar-3	ovarian:	n/a
14	chr9:3181772-3181822	RPTEC	kidney:	n/a
15	chr9:3180869-3180919	HRPEpiC	eye:	n/a
16	chr9:3183159-3183209	LNCaP	prostate:	n/a
17	chr9:3183159-3183209	PFSK-1	brain:	n/a
18	chr9:3181659-3181709	GM12878	blood:	n/a
19	chr9:3180374-3180424	HRE	kidney:	n/a
20	chr9:3181772-3181822	Hepatocyte	liver:	n/a
21	chr9:3183159-3183209	BE2_C	brain:	n/a
22	chr9:3183159-3183209	HNPCEpiC	eye:	n/a
23	chr9:3181007-3181057	GM06990	blood:	n/a
24	chr9:3183159-3183209	HL-60	blood:	n/a
25	chr9:3181659-3181709	HEK293	kidney:	embryo
26	chr9:3181659-3181709	PANC-1	pancreas:	n/a
27	chr9:3180869-3180919	ECC-1	luminal epithelium:	n/a
28	chr9:3180374-3180424	HAEpiC	amniotic membrane:	n/a
29	chr9:3181659-3181709	A549	lung:	n/a
30	chr9:3183159-3183209	SK-N-SH	brain:	n/a
31	chr9:3181007-3181057	HCF	heart:	n/a
32	chr9:3180869-3180919	IMR90	lung:	fetal
33	chr9:3181772-3181822	A549	lung:	n/a
34	chr9:3180869-3180919	AG04449	skin:	fetal
35	chr9:3180374-3180424	T-47D	breast:	n/a
36	chr9:3181659-3181709	HUVEC	blood vessel:	n/a
37	chr9:3181659-3181709	HCT-116	colon:	n/a
38	chr9:3181007-3181057	IMR90	lung:	fetal
39	chr9:3180869-3180919	SK-N-SH_RA	brain:	n/a
40	chr9:3181659-3181709	HRE	kidney:	n/a
41	chr9:3181007-3181057	HEEpiC	esophagus:	n/a
42	chr9:3183159-3183209	AG09309	skin:	n/a
43	chr9:3181772-3181822	ECC-1	luminal epithelium:	n/a
44	chr9:3180869-3180919	U87	brain:	n/a
45	chr9:3183159-3183209	ovcar-3	ovarian:	n/a
46	chr9:3181007-3181057	MCF10A-Er-Src	breast:	n/a
47	chr9:3180869-3180919	HL-60	blood:	n/a
48	chr9:3181772-3181822	SK-N-MC	brain:	n/a
49	chr9:3180869-3180919	HRE	kidney:	n/a
50	chr9:3181772-3181822	K562	blood:	n/a

(count:16 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr9:3216782..3218740-chr9:3229767..3232121,2	K562	blood:
2	chr9:3153271..3155559-chr9:3163455..3165401,2	K562	blood:
3	chr9:3218527..3221399-chr9:3268473..3270542,2	K562	blood:
4	chr9:3153271..3155559-chr9:3163455..3165401,2	K562	blood:
5	chr9:3216782..3218740-chr9:3229767..3232121,2	K562	blood:
6	chr9:3189825..3191620-chr9:3192425..3195414,2	MCF-7	breast:
7	chr9:3254757..3256417-chr9:3258277..3260050,2	K562	blood:
8	chr9:3240593..3241339-chr9:4375132..4375774,2	MCF-7	breast:
9	chr9:3240483..3241298-chr9:3440976..3441796,6	MCF-7	breast:
10	chr9:3239523..3241471-chr9:3244175..3245979,2	MCF-7	breast:
11	chr9:3239523..3241471-chr9:3244175..3245979,2	MCF-7	breast:
12	chr9:3189825..3191620-chr9:3192425..3195414,2	MCF-7	breast:
13	chr9:3235405..3237128-chr9:3237566..3239202,2	MCF-7	breast:
14	chr9:3254757..3256417-chr9:3258277..3260050,2	K562	blood:
15	chr9:3235405..3237128-chr9:3237566..3239202,2	MCF-7	breast:
16	chr9:2695521..2698232-chr9:3222806..3225730,2	K562	blood:

(count:15 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KCNV2-2	chr9:3186918-3187035	XLOC_007268
2	lnc-KCNV2-2	chr9:3198186-3198924	NONHSAT130017
3	lnc-KCNV2-2	chr9:3200300-3200500	NONHSAT130017
4	lnc-KCNV2-2	chr9:3193460-3193594	NONHSAT130017
5	lnc-KCNV2-6	chr9:3171589-3171889	NONHSAT130016
6	lnc-KCNV2-2	chr9:3181589-3181889	XLOC_007268
7	lnc-RFX3-1	chr9:3213829-3214127	expReg_chr9_150_-
8	lnc-KCNV2-6	chr9:3183460-3183594	NONHSAT130016
9	lnc-KCNV2-6	chr9:3176918-3177035	NONHSAT130016
10	lnc-KCNV2-2	chr9:3198186-3198517	XLOC_007268
11	lnc-KCNV2-6	chr9:3188186-3188517	NONHSAT130016
12	lnc-KCNV2-2	chr9:3193460-3193594	XLOC_007268
13	lnc-AL365202.1-2	chr9:3218302-3223008	NONHSAT130018
14	lnc-KCNV2-2	chr9:3186918-3187035	NONHSAT130017
15	lnc-KCNV2-2	chr9:3181589-3181889	NONHSAT130017

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	RFX3	hsa-miR-148b-3p	chr9:3224660-3224686

Variant related genes	Relation type
RFX3	TF binding region
ENSG00000236511	TF binding region
RFX3	CpG island
ENSG00000236511	CpG island
RAG1	miRNA target sites
CNOT6L	miRNA target sites

Extended variants
information (count: 4207 )
Associated
traits (count: 106 )

Variant overlapped rSNPs/rCNVs (count:4207 , 50 per page) page: 1 2 3 4 5 6 7 ... 85

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs145482872	chr9:3139007-3139008	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs368625628	chr9:3139026-3139027	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs186725080	chr9:3139045-3139046	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs78049314	chr9:3139078-3139079	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs531258824	chr9:3139108-3139109	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs113010812	chr9:3139142-3139143	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs114698256	chr9:3139160-3139161	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs572929822	chr9:3139177-3139178	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs145853028	chr9:3139199-3139200	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs192081656	chr9:3139215-3139216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs182899319	chr9:3139239-3139240	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs386731780	chr9:3139244-3139245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs486857	chr9:3139245-3139246	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs7039721	chr9:3139274-3139275	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs533769938	chr9:3139280-3139281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs138491159	chr9:3139296-3139297	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs141332615	chr9:3139338-3139339	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs571063087	chr9:3139344-3139345	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs536555742	chr9:3139362-3139363	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs369689912	chr9:3139456-3139457	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs576202302	chr9:3139470-3139471	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs373550470	chr9:3139474-3139475	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs192565333	chr9:3139501-3139502	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs113064643	chr9:3139515-3139516	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs542450235	chr9:3139523-3139524	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs550253637	chr9:3139525-3139526	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs540193705	chr9:3139526-3139527	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs570021673	chr9:3139534-3139535	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs138855581	chr9:3139583-3139584	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs113453437	chr9:3139584-3139585	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs34741680	chr9:3139586-3139587	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs7029475	chr9:3139596-3139597	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs7040290	chr9:3139673-3139674	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs531910145	chr9:3139721-3139722	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs6476283	chr9:3139726-3139727	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs115974359	chr9:3139727-3139728	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs7867500	chr9:3139753-3139754	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs141493528	chr9:3139774-3139775	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs7857427	chr9:3139784-3139785	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs536122890	chr9:3139792-3139793	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs7854436	chr9:3139802-3139803	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs72695074	chr9:3139807-3139808	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs182127200	chr9:3139815-3139816	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs7868524	chr9:3139855-3139856	Weak transcription Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs577667519	chr9:3139860-3139861	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs561680976	chr9:3139874-3139875	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs150822196	chr9:3139889-3139890	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs79805885	chr9:3139899-3139900	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs573679779	chr9:3139906-3139907	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs527338460	chr9:3139910-3139911	Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:106)

Disease	PMID	Source
Gastric cancer	16715143	CNVD
Glioblastoma multiforme	22286061	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Intracranial aneurysm	16715129	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Disorders of sex development	22290220	CNVD
Glioblastoma multiforme	21080181	CNVD
Sudden cardiac death	19188705	CNVD
Non-small cell lung cancer	21829676	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21183584	CNVD
Non-small cell lung cancer	21952639	CNVD
Disorders of sex development	21048976	CNVD
Neuroblastoma	18923191	CNVD
Intellectual disability	22102821	CNVD
abnormal development	18461090	CNVD
Honadal dysgenesis	21048976	CNVD
Medulloblastoma	21979893	CNVD
Lung cancer	16740712	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Developmental delay	21147756	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Lung cancer	18438408	CNVD
Autism	20531469	CNVD
XY gonadal dysgenesis	20685758	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Myelodysplastic syndrome	21251322	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Myelofibrosis	22110671	CNVD
Developmental delay	21373258	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Hepatocellular carcinoma	18803288	CNVD
Ovarian cancer	22355333	CNVD
Autism	20808228	CNVD
Pancreatic cancer	17952125	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Renal cell carcinoma	21215367	CNVD

Chromatin state (count:904 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:3136800-3139200	Enhancers	HSMM	muscle
2	chr9:3136800-3139200	Enhancers	HSMMtube	muscle
3	chr9:3137200-3139400	Enhancers	Muscle Satellite Cultured Cells	--
4	chr9:3137600-3139200	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
5	chr9:3138400-3140000	Weak transcription	Primary hematopoietic stem cells	blood
6	chr9:3138600-3139200	Enhancers	Osteobl	bone
7	chr9:3138800-3139200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr9:3139000-3139200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
9	chr9:3139000-3139200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr9:3139800-3140400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr9:3140000-3140800	Enhancers	Primary hematopoietic stem cells	blood
12	chr9:3140200-3140600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
13	chr9:3148600-3150200	Enhancers	HepG2	liver
14	chr9:3148800-3149000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr9:3149000-3151400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr9:3149400-3151400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr9:3149600-3150000	Enhancers	Fetal Muscle Trunk	muscle
18	chr9:3149600-3150600	Enhancers	Fetal Muscle Leg	muscle
19	chr9:3150000-3150400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
20	chr9:3150200-3150600	Flanking Active TSS	HepG2	liver
21	chr9:3150600-3151400	Enhancers	HepG2	liver
22	chr9:3151200-3152200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
23	chr9:3151400-3151800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr9:3151400-3152200	Enhancers	Fetal Intestine Large	intestine
25	chr9:3151400-3152400	Enhancers	Fetal Intestine Small	intestine
26	chr9:3151400-3152800	Flanking Active TSS	HepG2	liver
27	chr9:3151800-3152000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
28	chr9:3152000-3152200	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr9:3152800-3153600	Enhancers	Primary neutrophils fromperipheralblood	blood
30	chr9:3152800-3153800	Enhancers	HepG2	liver
31	chr9:3153000-3153400	Enhancers	Primary monocytes fromperipheralblood	blood
32	chr9:3153800-3157200	Weak transcription	HepG2	liver
33	chr9:3156600-3157400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr9:3157200-3157600	Enhancers	HepG2	liver
35	chr9:3167200-3167400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
36	chr9:3167800-3168200	Enhancers	Primary hematopoietic stem cells	blood
37	chr9:3168000-3168200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
38	chr9:3169600-3170200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr9:3173200-3174000	Enhancers	HepG2	liver
40	chr9:3173400-3174000	Enhancers	Fetal Intestine Large	intestine
41	chr9:3173800-3174200	Enhancers	Rectal Mucosa Donor 31	rectum
42	chr9:3174000-3175000	Weak transcription	HepG2	liver
43	chr9:3174000-3176400	Weak transcription	Fetal Intestine Large	intestine
44	chr9:3174200-3177000	Weak transcription	Rectal Mucosa Donor 31	rectum
45	chr9:3174400-3178200	Enhancers	Primary hematopoietic stem cells	blood
46	chr9:3175000-3177200	Enhancers	HepG2	liver
47	chr9:3175400-3178200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
48	chr9:3175400-3178200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
49	chr9:3175600-3177600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
50	chr9:3175600-3177800	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links